Industry Veteran Brings Legal, Transactional and Commercial Compliance Expertise
"I am excited to join Trius as the company prepares to file for regulatory approval of tedizolid," stated Mr. Onaitis. "We are at a key juncture of Trius' development as a company and I am pleased to be a part of its leadership team as we advance to the next levels of value creation from tedizolid and our pipeline programs."
Um, if you are looking to sell or merge, this is exactly what you do: bring in lawyers and other consultants prior to a sale or merger. What exactly do you think "transactional" means? You don't sell your company without a cadre of lawyers around.
I don't know that this is indicative of a sale, but your logic is really, really flawed if you think it's indicative of the company not being sold.
"Matt has broad legal experience with both development-stage and commercial-stage pharmaceutical companies," stated Jeffrey Stein, President and CEO of Trius Therapeutics. "In particular, his background in completing transactions,........."